Overview

A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the blood and airway of subjects with mild to moderate COPD while undergoing standard treatment.
Phase:
Phase 1
Details
Lead Sponsor:
University of Chicago
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone
Salmeterol Xinafoate